Literature DB >> 34223117

WHO/INRUD core prescribing indicators and antibiotic utilization patterns among primary health care facilities in Ilala district, Tanzania.

Amosi Kilipamwambu1, George M Bwire2, David T Myemba2, Belinda J Njiro1, Mtebe V Majigo1.   

Abstract

BACKGROUND: Antibiotic use requires regular monitoring to prevent emergence of antibiotic resistance.
OBJECTIVES: To assess antibiotic prescribing patterns at health care facilities (HCF) in Ilala district, Tanzania.
METHODS: A 1 year retrospective study was conducted in four HCFs using WHO/International Network of Rational Use of Drugs (INRUD) core prescribing indicators. Factors associated with antibiotic prescription were analysed using logistic regression model.
RESULTS: A total of 604 prescriptions were reviewed. Patients had median age (IQR) of 15 (4-31) years with majority having upper respiratory tract infection 33.3% (n = 201), urinary tract infection 31.1% (n = 188) or diarrhoea 21.2% (n = 128). Out of 624 prescribed antibiotics, amoxicillin was the most common (22.7%), followed by ciprofloxacin (13.6%) and metronidazole (11.6%). The studied HCFs had an average of 1.99 medicines prescribed per consultation (reference: 1.6-1.8). Of 1203 medicines prescribed, 51.9% (n = 624) were antibiotics (reference: 20.0%-26.8%). Additionally, 97.6% (n = 609) of the antibiotics appeared on the national essential medicines list, whereby 84.4% (n = 510) were prescribed by generic names (reference: 100%). Patients with peptic ulcers had a 4.4-fold higher chance of receiving antibiotics [adjusted odds ratio (aOR) = 4.4, 95% CI = 1.918-10.13, P = 0.0001] while patients with diarrhoea had a 2.6-fold higher chance of receiving at least one antibiotic (aOR = 2.6, 95% CI = 1.206-5.491, P = 0.015).
CONCLUSIONS: We found inappropriate use of antibiotics in the studied primary HCFs. Antibiotic stewardship programmes should be extended to primary HCFs found in Ilala district.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Entities:  

Year:  2021        PMID: 34223117      PMCID: PMC8210294          DOI: 10.1093/jacamr/dlab049

Source DB:  PubMed          Journal:  JAC Antimicrob Resist        ISSN: 2632-1823


Introduction

Antibiotic use remains one of the most cost‐effective health interventions in the fight against infectious diseases caused by bacteria. However, inappropriate antibiotics use may result in the emergence of resistant bacteria. This in turn threatens the achievements made in the past decades in the prevention and control of infectious diseases. A resistant bacterium requires expensive antibiotics and long hospitalization period, which has both health and financial consequences in human medicine. To prevent the emergence of antibiotic resistance and its effects on human health, WHO recommends routine monitoring of antibiotic use. In 1993, the WHO in collaboration with the International Network of Rational Use of Drugs (INRUD) formulated a list of selected indictors to investigate drug use in health facilities. The WHO/INRUD developed core prescribing indicators, such as an average number of medicines prescribed per consultation (optimal value 1.6–1.8), the percentage of drugs prescribed by generic name (optimal value 100%), the percentage of encounters where an antibiotic was prescribed (optimal value 20.0%–26.8%), the percentage of encounters where injections were prescribed (optimal value 20.0%–26.8%) and medicines prescribed from the Essential Drugs List (optimal value 100%)., Despite the existence of well-established standards for guiding the prescription practice at health care facilities (HCF), several studies have indicated substantial overuse of common antibiotics across developing countries, particularly in primary healthcare centres. To this end, Tanzania as an implementing partner has a National Essential Medicines List (NEML) and treatment guidelines that guide the use of antibiotics at the HCF level. However, the current information on antibiotic prescribing practice in Tanzania is limited. Therefore, we aimed to study antibiotic prescribing indicators and utilization patterns among outpatients attending care at primary health centres in Ilala district.

Methods

Study design, period and settings

This was a 1 year retrospective cross-sectional study, data from September 2018 to September 2019 was used in assessing antibiotic prescribing practice and utilization patterns in health centres at four primary health care centres in Ilala District, Tanzania. The study was conducted from October 2019 to January 2020. Ilala district (found in the Dar es Salaam region) has a total population of 1 220 611 with a very large population change of about 92.2% from 2002 to 2012. The district has about 20 health centres at the time of conducting this study; three public and one private were selected based on the availability of an electronic system known as the Government of Tanzania-health online management information system (GOT-HOMIS). Additionally, we included health centres that have installed and using GOT-HOMIS for more than 1 year.

Study population

This study was conducted in among outpatients who represents about 90% of all antibiotic usage. Data about study participants were collected from the patients’ electronic files through GOT-HOMIS. Information about age, sex, infectious conditions (suspected or confirmed infection), investigation, drugs prescribed and payment plan were collected. WHO recommends that there should be at least 600 encounters included in a cross-sectional survey. We included four primary health care centres, with about 150 encounters per facility. Four health care facilities (HCFs) were selected randomly from the Ilala district list of primary health care centres in Tanzania, but the presence of GOT-HOMIS determined their final inclusion. The sampling ensured the inclusion of both public and private primary health care centres. The number of encounters per HCF was systematically selected to have at least 150 samples from each facility. The sampling interval ‘n = 4’ was determined as the proportion of 600 encounters over 150 samples. Then patient’s file was sampled after every ‘nth’ interval.

Data analysis

Data were collected using an Open Data Kit (ODK software, USA) by adapting the WHO data collection guideline as previously study done by Mashalla et al. Data were exported from the ODK server to a Microsoft Excel sheet (Redmond, WA) then exported to a statistical package for social science (SPSS version 25, Chicago Inc., USA) for analysis. Descriptive statistics such as frequencies, percentages, averages (SD) and median (IQR) were summarized using frequency distribution tables. The predictors for laboratory investigation and prescription of antibiotics were determined using binary logistic regression model. Factors with P value <0.2 in univariate qualified for multivariate analysis. A P value <0.05 was considered statistically significant with 95% CI. Relationship between antibiotics classes and the disease conditions were presented using 2-D dot-plot graph. In order to assess the prescribing practices using WHO/INRUD prescribing indicators (average number of medicines prescribed per consultation, the percentage of drugs prescribed by generic name, the percentage of encounters where an antibiotic was prescribed, the percentage of encounters where injections were prescribed and medicines prescribed from the Essential Drugs List), the optimal values/reference standards were adopted from a previous study.

Ethics

Ethics clearance was obtained from Muhimbili University of Health and Allied Sciences Ethical Committee (Reference number: DA.25/111/01/). Additionally, research permission was sought from the Ilala District Medical Officer, and upon entry to the respective ward and health centre, at each study site permission was sought from the Medical Officer in charge of the respective health facility. Privacy and confidentiality were observed, the identity of the participants was not recorded from the dataset used to store the information of health records at the healthcare facility.

Results

Characteristics of participants and selected clinical parameters

A total of 604 prescriptions were reviewed with most of the patients being female (54.1%; n = 327). Patients had a median age (IQR) of 15 (4–31) years with most of the patients having attended the public health centres 75% (n = 435). One-third of patients were suspected to have upper respiratory tract infection (URTI) 33.3% (n = 201) (Table 1).
Table 1.

Participants sociodemographic and clinical characteristics

CharacteristicsFrequency (n)Percentage (%)
Sex
 Female32754.1
 Male27745.9
Age group, years, [median (IQR): 15 (4–31)]
< 519832.8
 5–149816.2
 15–248413.9
 25–4414423.8
 45–65599.8
> 65213.5
Health facility category
 Public45375
 Private15125
Payment method
 Insurance19432.1
 User fee41067.9
Laboratory investigation done
 Yes32153.1
 No28346.9
Number of laboratory investigations
 None28346.9
 One8614.2
 Two13622.5
 Three9916.4
Common disease conditions
 URTI20133.3
 UTI18831.1
 Diarrhoea12821.2
 Skin infection7211.9
 Peptic ulcers152.5
Number of antibiotics per prescription
 None8013.2
 143471.9
29014.2

URTI, upper respiratory tract infection; UTI, urinary tract infection.

Participants sociodemographic and clinical characteristics URTI, upper respiratory tract infection; UTI, urinary tract infection.

Selected WHO/INRUD prescribing indicators

A total of 1203 drugs were prescribed from the 604 analysed prescriptions. The studied health centres in Ilala district had an average of 1.99 (SD = 0.7) medicines prescribed per consultation and an average of 84% (n = 510) of the antibiotics were prescribed by generic name. Additionally, 51.9% (n = 624) of all outpatient encounters was prescribed antibiotics during the reviewed consultations. In these primary health facilities, on average 97.6% (n = 609) of the antibiotics appeared on the national essential drugs list while 3.2% (n = 38) of the encounters were prescribed injections (Table 2).
Table 2.

The selected core WHO/INRUD prescribing indicators

ParameterFrequencyPercentage (%)Reference standards11
Average number of drugs per encounter1.99 (SD: 0.7)1.6–1.8
Encounters prescribed antibiotics62451.920.0%–26.8%
Encounters prescribed injections383.213.4%–24.1%
Antibiotics prescribed are generics51084.4100%
Antibiotics prescribed in the essential medicine lista60997.6100%
Total number of prescriptions analysed604
Total number of drugs prescribed1203

National Essential Medicines List.

The selected core WHO/INRUD prescribing indicators National Essential Medicines List.

Commonly prescribed antibiotics

Out of 624 prescriptions containing antibiotics, amoxicillin was the most common (22.7%) followed by ciprofloxacin (13.6) then metronidazole (11.6%). In terms of classes, penicillins were the most prescribed antibiotics (44.7%) followed by fluoroquinolones (15.8%) (Figure 1).
Figure 1.

Commonly prescribed antibiotics (a) and their classes (b).

Commonly prescribed antibiotics (a) and their classes (b).

Class of antibiotics prescribed by conditions encountered

Penicillins were commonly used to treat URTI, nitroimidazoles for diarrhoea and fluoroquinolones for urinary tract infection. Aminoglycosides were rarely used for treatment diarrhoea, skin and URTI (Figure 2).
Figure 2.

Class of antibiotics prescribed by condition encountered.

Class of antibiotics prescribed by condition encountered.

Predictors for laboratory investigation in the suspected infected patients

The univariate analysis found that patients with peptic ulcers had a 4.6-fold higher chance of having laboratory investigation as compared with those patients with skin infections [crude odds ratio (cOR) = 4.6, 95% CI = 2.92–7.131, P = 0.0001], which was similar to the multivariate analysis [adjusted OR (aOR)=5.0, 95% CI = 3.1–8.126, P = 0.0001]. Public health centres were more likely to conduct laboratory investigations before antibiotic prescription as compared with private health care centres by univariate (cOR = 2.6, 95% CI = 1.691–3.709, P = 0.001) and multivariate analysis (aOR = 2.9, 95% CI: 1.887–4.512, P = 0.0001) (Table 3).
Table 3.

Predictors for laboratory investigation for the suspected infectious disease

Univariate analysis
Multivariate analysis
VariableCategoriescOR95% CI P valueaaOR95% CI P valuea
Age (years) < 50.90.343–2.080.7131.20.423–3.410.73
5–141.90.73–4.900.1872.10.709–6.2640.18
15–241.40.64–3.640.4941.40.458–4.1350.569
25–441.30.52–3.250.5751.10.371–3.0720.903
25–642.00.73–5.360.1811.80.557–5.6330.333
65Ref
SexMale1.20.89–1.700.2051.00.741–1.5470.717
FemaleRef
Payment methodUser fee0.80.572–1.1340.2150.70.481–1.0420.08
InsuranceRef
Disease conditionUTI0.90.614–1.4990.9591.00.647–1.6570.885
URTI3.41.045–11.01 0.042 2.60.779–8.960.119
Diarrhoea0.40.189–0.656 0.001 0.30.183–0.663 0.001
Peptic ulcers4.62.92–7.131 0.0001 5.03.1–8.126 0.0001
Skin infectionRef
Hospital categoryPublic2.61.691–3.709 0.0001 2.91.887–4.512 0.0001
PrivateRef

Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection.

P values < 0.05 are shown in bold.

Predictors for laboratory investigation for the suspected infectious disease Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection. P values < 0.05 are shown in bold.

Factors associated with antibiotic prescription

Patients presented with peptic ulcers were 4.4-fold more likely to receive antibiotics as compared with those with skin infections (aOR = 4.4, 95% CI = 1.918–10.13, P = 0.0001). Compared with those with skin infections, patients with diarrhoea had 70% chance of not being prescribed antibiotics (aOR = 0.3, 95% CI = 0.133–0.489, P = 0.001) (Table 4).
Table 4.

Factor associated with antibiotics prescription

Univariate analysis
Multivariate analysis
VariableCategoriescOR95% CI P valueaaOR95% CI P valuea
SexMale1.30.75–2.0390.3151.80.933–3.3250.081
FemaleRef
Payment methodUser fee0.80.494–1.3220.2150.70.416–1.1770.178
InsuranceRef
Disease conditionUTI1.20.613–2.2720.621.20.623–2.330.581
URTI2.40.299–18.640.4152.40.295–19.1030.417
Diarrhoea0.30.16–0.555 0.0001 0.30.133–0.489 0.0001
Peptic ulcers3.81.687–8.529 0.001 4.41.918–10.130 0.0001
Skin infectionRef
Hospital categoryPublic1.50.838–2.752 0.0001 1.80.933–3.3250.081
PrivateRef
Laboratory investigationYes1.30.810–2.0790.2780.70.416–1.1770.178
No

Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection.

P values < 0.05 are shown in bold.

Factor associated with antibiotics prescription Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection. P values < 0.05 are shown in bold.

Factors associated with prescription of more than one antibiotic

Patients with diarrhoea were 2.6-fold more likely to be prescribed with more than one antibiotic as compared with those with skin infections by both univariate (cOR = 2.6, 95% CI = 1.239–5.451, P = 0.012) and multivariate analysis (aOR = 2.6, 95% CI = 1.206–5.491, P = 0.015) (Table 5).
Table 5.

Predictors for being prescribed with more than one antibiotic

Univariate analysis
Multivariate analysis
VariableCategoriescOR95% CI P valueaOR95% CI P value
Age (years) < 50.90.3–2.5550.8071.00.334–3.0380.990
5–140.40.13–1.3870.1870.50.142–1.6050.232
15–240.70.2–2.1190.4940.70.223–2.5050.637
25–440.70.238–2.170.5750.80.261–2.5370.723
25–640.30.082–1.2490.1010.40.091–1.460.154
65Ref
SexMale0.930.591–1.470.7631.00.59–1.5730.881
FemaleRef
Payment methodUser fee0.90.524–1.4190.560.90.544–15100.705
InsuranceRef
Disease conditionUTI1.00.497–1.8590.9060.90.481–1.8320.853
URTI0.90/190–4.2270.8891.20.241–5.7740.638
Diarrhoea2.61.239–5.451 0.012 2.61.206–5.491 0.015
Peptic ulcers1.00.582–1.8270.9161.1.0.585–2.0510.777
Skin infectionRef
Hospital categoryPublic0.60.349–1.0880.0950.5890.324–1.0710.082
PrivateRef
Lab investigationYes0.70.469–1.1650.1941.20.65–2.3970.506
NoRef
No. lab testsNone1.50.804–2.6280.216
One1.00.42–2.2280.9391.00.0406–2.2730.927
Two1.30.608–2.7170.5101.40.644–2.9740.406
ThreeRef

Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection.

P values < 0.05 are shown in bold.

Predictors for being prescribed with more than one antibiotic Ref, reference category predicted the probability of laboratory investigation (yes); cOR, crude odds ratio; aOR, adjusted odds ratio; URTI, upper respiratory tract infection; UTI, urinary tract infection. P values < 0.05 are shown in bold.

Discussion

We examined 604 encounters and found poor antibiotics prescription practice as compared to the WHO optimal values. The studied health centres in Ilala district had an average of 1.99 medicines prescribed per consultation; of those medicines, 51.9% were antibiotics. An average of 84% of the antibiotics was prescribed by its generic name. Additionally, these primary health facilities had an average of 97.6% of the antibiotics that appeared on the NEML, while 3.2% of the encounters were prescribed injections. These results were similar to the previous findings, which found a proportion of prescriptions with injections of 18.1% while those containing antibiotics was 67.7%, and the average number of medicines per prescription was 2.3. The proportion of medicines prescribed by generic name was 95.7%, while the proportion that contained medicines in line with the NEML was 96.7%. Except for prescribed injections, other core indicators exceeded the optimal values recommended by WHO, implying inappropriate prescriptions in the study area. A systematic review done by Ofori-Ansenso et al. 2016 indicated that the overall antibiotic prescription rate in Africa was 46.8%, whereas Tanzania had a 58% prescription rate. These previous findings were higher compared with our current study (51.9%). Nonetheless, both findings are still higher than the WHO targets but lower than those conducted elsewhere., We found a relatively high adherence level of 97.6% to the respective NEML recommendation, although this is inconsistent with the recommendation by WHO to fully (100%) adhere to the list. The situation is similar in other countries in the region. A study by Mashalla et al. 2017 in Botswana reported a 96.1% adherence. A constantly high prescription of antibiotics implies the increase of non-adherence to treatment guidelines within specified countries. A possible explanation could be that healthcare providers prescribe antibiotics despite their sound clinical judgement in meeting patients’ demands. Also, most antibiotics available at primary health facilities are used for the management of common and relatively uncomplicated infections. This may prompt physicians to seek alternative medicine not listed in NEML. Other factors such as patients, healthcare providers, the working environment, the drug companies, legal regulations, information and misinformation about medicines, and market forces could be associated with non-compliance with appropriate antibiotic use., These differences can sometimes be attributed to the differences in the study population, for example, the study by Atif et al., was conducted at an Emergency Department. The classes of antibiotics commonly prescribed were penicillins (amoxicillin), fluoroquinolones (ciprofloxacin), and nitroimidazoles (metronidazole) in that order. Antibiotic class prescription was examined in relation to the clinical conditions, and penicillin and fluoroquinolones were more commonly prescribed for urinary tract infections, and nitroimidazoles were frequently prescribed for diarrhoea. These were similar to a study conducted in Ethiopia where, penicillins 51.9% (amoxicillin: 44.8%) and fluoroquinolones 18.3% (ciprofloxacin: 13.6%) were most common. This similarity could be due to shared clinical conditions and treatment practices in tropical regions. The prescriptions of antibiotics mostly complied with the NEML recommendation. It should be noted that the prescription of antibiotics in primary health care in Tanzania is not necessarily guided by bacterial culture and antimicrobial susceptibility testing results. Some guidelines, such as integrated management of childhood illness (IMCI) recommend no antibiotics for some conditions that are mostly viral in origin. Nevertheless, empirical treatment was frequently encountered, for example children with diarrhoea were empirically treated with cotrimoxazole and erythromycin. Patients with peptic ulcers were more likely to receive antibiotics, and those with diarrhoea had a higher chance of being prescribed more than one antibiotic. However, the question remains whether the diagnosis of peptic ulcers was correctly made, given that the primary health centres in Tanzania have limited laboratory capacity to perform microbiological tests. A follow-up qualitative study on why there is high prescription rate among patients with peptic ulcers is recommended. Since primary health care centres in Ilala district, Tanzania rarely have inpatients, conclusions from this study are limited to outpatients. Four HCF were included with only one private HCF, given the possibility of site bias as a result of including only one private health care centre, interpretation of practice in private facilities should be done with care. We acknowledge the limitations based on the study design used, retrospective studies had a characteristic of having documentation and reporting bias. However, data collection ensured that all required data were collected accordingly. During data collection it was not clear what type of diarrhoea was documented (non-bloody diarrhoea or bloody diarrhoea), this poses potential limitations to the conclusion. Nonetheless, in managing diarrhoea antibiotics use is less prioritized.

Conclusions

We found inappropriate prescriptions of antibiotics in the studied primary health care facilities in Ilala District. Factors such as disease condition strongly predicted the prescription practice. It was found that patients with peptic ulcers had higher chance of receiving antibiotics, which were rarely prescribed to patients with diarrhoea. However, patients with diarrhoea were more likely to receive at least one antibiotic. URTI was the commonly diagnosed infection, followed by urinary tract infection, then diarrhoea. Amoxicillin was the leading prescribed antibiotic, followed by ciprofloxacin then metronidazole. Antibiotics stewardship programmes should be extended to primary health care facilities in Ilala district. This will include prescription based on bacterial culture and susceptibility testing, formulating strategies for management of URTI, reducing inappropriate prescription for viral infection and adhering to national treatment guidelines. Lastly, a regionwide cross-sectional survey study is warranted.
  9 in total

Review 1.  How can we improve antibiotic prescribing in primary care?

Authors:  Oliver J Dyar; Bojana Beović; Vera Vlahović-Palčevski; Theo Verheij; Céline Pulcini
Journal:  Expert Rev Anti Infect Ther       Date:  2016-02-24       Impact factor: 5.091

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: Findings and implications.

Authors:  Yohana Mashalla; Vincent Setlhare; Amos Massele; Enoch Sepako; Celda Tiroyakgosi; Joyce Kgatlwane; Mpo Chuma; Brian Godman
Journal:  Int J Clin Pract       Date:  2017-11-27       Impact factor: 2.503

4.  Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial.

Authors:  Bernard C Camins; Mark D King; Jane B Wells; Heidi L Googe; Manish Patel; Ekaterina V Kourbatova; Henry M Blumberg
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

5.  Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa.

Authors:  Faith Moyo; Charles Chasela; Alana T Brennan; Osman Ebrahim; Ian M Sanne; Lawrence Long; Denise Evans
Journal:  Clin Epidemiol       Date:  2016-03-18       Impact factor: 4.790

6.  WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan.

Authors:  Muhammad Atif; Muhammad Azeem; Muhammad Rehan Sarwar; Samia Shahid; Sidra Javaid; Huria Ikram; Uzma Baig; Shane Scahill
Journal:  Springerplus       Date:  2016-11-08

7.  Retrospective Assessment of Antibiotics Prescribing at Public Primary Healthcare Facilities in Addis Ababa, Ethiopia.

Authors:  Fikru Worku; Dagmawit Tewahido
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-02-28

8.  Evaluation of antibiotic prescriptions and use in under-five children in Ibadan, SouthWestern Nigeria.

Authors:  Rasaq Adisa; Ochuko M Orherhe; Titilayo O Fakeye
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

9.  Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015).

Authors:  Richard Ofori-Asenso; Petra Brhlikova; Allyson M Pollock
Journal:  BMC Public Health       Date:  2016-08-22       Impact factor: 3.295

  9 in total
  1 in total

1.  Adherence to Antiretroviral Therapy and Associated Factors Among People Living With HIV Following the Introduction of Dolutegravir Based Regimens in Dar es Salaam, Tanzania.

Authors:  Mary Spicar Kilapilo; Raphael Zozimus Sangeda; George M Bwire; Godfrey Leonard Sambayi; Idda Hubert Mosha; Japhet Killewo
Journal:  J Int Assoc Provid AIDS Care       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.